Objective: To compare the clinical, radiographic and medium-term follow-up results from two fixation methods for the tibial component in revision procedures on total knee prostheses: cemented (tray and stem) and hybrid (cemented tray and uncemented, nonporous canal-filling stem). Methods: Between August 1999 and November 2005, 30 revision procedures on total knee arthroplasties were performed on 26 patients, who were divided between group I (cemented fixation; 21 knees) and group II (hybrid fixation; nine knees). The mean follow-up was 52 months and no patients were lost from the follow up. Results: No differences in the scores from the WOMAC and Knee Society questionnaires were observed between the two groups. One patient in group I presented radiographic signs of loosening. Two patients (one in each group) complained of pain in the diaphyseal region, compatible with the location of the stem tip. The pedestal radiographic sign was observed in 89% of the knees with uncemented stems and in none of the cemented group. Conclusion: The comparative analysis between the two methods did not show any differences regarding clinical and radiographic parameters, or arthroplasty survival.
OBJECTIVES:To study the role of angiogenesis and cyclooxygenase-2 expression in cartilaginous tumors and correlate these factors with prognosis.INTRODUCTION:For chondrosarcoma, the histological grade is the current standard for predicting tumor outcome. However, a low-grade chondrosarcoma can follow an aggressive course—as monitored by sequential imaging techniques—even when it is histologically indistinguishable from an enchondroma. Therefore, additional tools are needed to help identify the biological potential of these tumors. The degree of angiogenesis that is induced by the tumor could assist in this task. Angiogenesis can be quantified by measuring the expression of vascular endothelial growth factor and CD34, and cyclooxygenase-2 can induce angiogenesis by stimulating the production of pro-angiogenic factors.METHODS:In total, 21 enchondromas and 58 conventional chondrosarcomas were studied by examining the clinical and histopathological findings in conjunction with the immunostaining markers of angiogenesis and cyclooxygenase-2 expression.RESULTS:The significant variables that were associated with poor outcome were 1) higher-grade chondrosarcomas, 2) tumors that developed in flat bones, and 3) over-expression of CD34 (with a median count that was higher than 5.9 vessels in 5 high power fields). Moreover, CD34 expression (measured using the Chalkley method) revealed significantly higher microvessel density in flat bone chondrosarcomas.DISCUSSION:Previous studies have shown a positive correlation between Chalkley microvessel density and histological grade; however, in our sample, we found that the former is predictive of the outcome. Chondrosarcomas in flat bones have been shown to correlate with a poor prognosis. We also found that CD34 microvessel density values were significantly higher in flat-bone chondrosarcomas. This could explain—at least in part—the more aggressive biological course that is taken by these tumors.CONCLUSIONS:These results provide evidence that CD34 microvessel density in chondrosarcomas can be helpful in predicting patient outcome and may add to our understanding of chondrosarcoma pathogenesis.
The results point to the use of the vascular pattern classification as a prognostic tool in CSs and to differentiate low-grade from moderate-grade/high-grade CSs. Vascular pattern might be also used to complement histologic grade, VEGF immunostaining, and microvascular density, for indicating a patient's prognosis. Low-grade CSs develop under low neoangiogenesis, which conforms to the slow growth rate of these tumors.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.